Autopsy report · NCT03599661

Developing and Validating Fertilit-e

“PI decision - competing study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 4 years 10 months before it stopped.
• 21 participants enrolled.
• Results were posted on the registry 1 year 7 months after it ended.

Vital statistics

Status

Terminated

Sponsor

Wake Forest University Health Sciences

Sponsor type

University, hospital or other

Conditions

Malignant Neoplasm

Interventions

Interview; Questionnaire Administration

Participants

21

Sites

1

Countries

United States

Trials that died the same way

• Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity
  “PI decision due to under accrual.” (72% match in meaning)
• Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis
  “Study closure based on decision of the PI” (68% match in meaning)
• Phase II Trial of Lurbinectedin Combined With Avelumab as Switch Maintenance Firstline Therapy
  “PI Decision based on no enrollment” (66% match in meaning)
• Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus
  “PI decision based on reduced staffing and funds.” (63% match in meaning)
• Value of 3D Modeling in Spine Surgery
  “Sponsor and PI decision” (61% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.